Page 54 - Catalysts for Fine Chemical Synthesis Vol 1 - Robert & Poignant
P. 54

the integration of biotransformations into catalyst        37

             complex  [151] . Subsequently many excellent metal-catalysed methods have been
             developed for asymmetric cyclopropanation [152] , most being trans-selective for
             the addition of diazo-ester to an alkene such as styrene: one example is shown
             in Scheme 50 [153] . Only a few catalysts (for example a ruthenium±salen system)
             have been found that promote asymmetric cyclopropanation to give cis-
             products [154] . The range of asymmetric reactions of diazoesters has been
             extended to additions to imines to furnish aziridine derivatives [155] .
               Finally allylic substitution reactions involving, for example, replacement of
             an acetate unit with a malonate residue (or other nucleophiles) has been re-
             searched extensively by Trost and co-workers [156] . This group originally used
             Pd(PPh 3 ) in the presence of a chiral phosphine to induce asymmetry but has
                     4
             shown more recently, inter alia, that the isomers (66) and (67) are both converted
             into the diester (68) in good yield and >95 % ee using the dipyridine ligand (69) in
             a molybdenum-based catalyst (Scheme 51). The extensive range of chiral cata-
             lysts that have been used to effect enantioselective C±C and C±heteroatom bond
             formation is such allyl displacement reactions has been reviewed [157] .



                            OCOMe
              O
                                        Na    Me          i
              or       (66)    +                                     O
                                     MeO 2 C   CO 2 Me                        H
                                                                   MeO 2 C   CO 2 Me
                                                                         Me
             O
                   OCOMe     (67)                                         (68)

             Scheme 51: Reagents and conditions: (i) 10 % (MeCN 3 Mo(CO) ligand (69).
                                                              3



                                       O              O
                                           NH HN

                                        N          N
                                             (69)





             1.5  CONCLUSIONS

             It is clear that in the following areas of synthetic chemistry the use of isolated
             enzymes or whole cell organisms should be considered (sometimes alongside
   49   50   51   52   53   54   55   56   57   58   59